Molecular Brain is an open access, peer-reviewed journal that considers manuscripts on all aspects of studies on the nervous system at the molecular, cellular, and systems level providing a forum for scientists to communicate their findings.
Molecular brain research is a rapidly expanding research field in which integrative approaches at the genetic, molecular, cellular and synaptic levels yield key information about the physiological and pathological brain. These studies involve the use of a wide range of modern techniques in molecular biology, genomics, proteomics, imaging and electrophysiology.
We are proud to announce a new Collection is open for submissions, guest edited by Mohammed R. Shaker and Jin-A Lee. We welcome original research articles and reviews, highlighting cutting-edge research that utilizes stem cells and organoids to unravel the complexities of the nervous system.
Find out more about the included topics here.
Image credit: © wigglestick / iStock / Getty Images Plus
Following on from recent popularity of the Micro Reports article type, we are delighted to announce the launch of a new format, the Nano Review.
Find out more about how these short articles will be putting forward the ‘big questions’ currently facing the neuroscience field.
Our current featured image is taken from a recent Molecular Brain short report, "The nuclear lamina is a hub for the nuclear function of Jacob"
Senior author Dr Anna Karpova from Leibniz-Institut für Neurobiologie says “This image shows binding of the synapto-nuclear protein messenger Jacob to the inner nuclear membrane protein LaminB1 revealed by proximity ligation assay (PLA) with Duolink FarRed signals (represented based on a RedHot look-up-table), which decorate the periphery of the DAPI-stained nucleus (blue) of a DIV17 hippocampal primary neuron. To our knowledge, this is the first time that PLA and STED imaging have been combined, allowing us to resolve multiple Jacob-LaminB1 complexes along the inner nuclear membrane."
We are delighted to showcase this image, alongside the full article, in Molecular Brain.
A year on from the launch of our boundary-pushing article type, Micro Reports, we're pleased to present a summary of the most popular submissions so far.
Micro Reports are suitable for presenting small amounts of data or research that otherwise remain unpublished, including important negative results, reproductions, or exciting findings that you wish to place rapidly into the public domain.
Find out more about how Micro Reports could be right for your research.
In partnership with Research Square, Molecular Brain is now offering In Review. Authors choosing this free optional service will be able to:
Read more about the full range of benefits of In Review and how to opt in, or see the In Review platform for yourself here.
Celebrating Donald O. Hebb's seminal work, The Organization of Behavior, the first articles in our new thematic series are now available.
Find out more and read the published articles here.
In this series of reviews, we take a look at the molecular basis of neural disorders. The topics addressed include: iPSC technology for autism models, CaMKII dysregulation in Alzheimer's disease, migroglia in neuropathic pain, metabotropic glutamate receptors in schizophrenia, and cortical kinate receptors in anxiety.
No major experimental revisions requested. We will not request major additional experiments during the peer-review process, as we believe that high-quality data should be published promptly without unnecessary delay.
Your browser needs to have JavaScript enabled to view this timeline
Molecular Brain is the official journal of the Association for the Study of Neurons and Diseases (AND). The AND is a not-for-profit organization for the study of mental health from a neurological perspective. The goal of AND is to enhance the quality and quantity of research and education as it pertains to the understanding and treatment of mental health issues.
“The brain is the most complex structure in the universe, yet it defines who we are. Molecular Brain is a fast, open access, online journal that publishes high quality papers and thus promotes communication among neuroscientists interested in revealing the mysteries of brain function at the molecular and cellular level."
Bong-Kiun Kaang, Editor-in-Chief, Molecular Brain
"One of the most significant driving forces in science is discovery in our daily research activity. At Molecular Brain, we believe the delay between the moment of discovery and publication should be as short as possible, but with high-quality and fair peer-review. By exploring and adopting new innovations and technology advances, I will strive to ensure Molecular Brain is the best place to publish your discovery in brain science. "
Tsuyoshi Miyakawa, former Editor-in-Chief
As of June 2020, Molecular Brain is delighted to announce Professor Graham Collingridge as our new co-Editor-in-Chief.
Graham has long been at the forefront of synaptic plasticity research, and will take on the responsibility of the journal's Reviews section, previously lead by Professor Tim Bliss.
A joint publication of BMC, part of Springer Nature, and the Editorial Group of Molecular Brain since 2008.
Molecular Brain is affiliated with the Association for the Study of Neurons and Disease (AND).
Citation Impact 2023
Journal Impact Factor: 3.3
5-year Journal Impact Factor: 3.8
Source Normalized Impact per Paper (SNIP): 0.844
SCImago Journal Rank (SJR): 1.315
Speed 2024
Submission to first editorial decision (median days): 15
Submission to acceptance (median days): 88
Usage 2024
Downloads: 993,076
Altmetric mentions: 429
Molecular Brain is a member of the Neuroscience Peer Review Consortium.
Molecular Brain has partnered with Publons to give you official recognition for your contribution to peer review. Create a free profile to have your reviews automatically added.
Molecular Brain